Instant pipeline

Synosis Therapeutics Inc. is looking to develop small molecules for neurological indications that have been put on the shelf by larger pharma companies. Last week, the company took in five compounds from Roche in its first in-licensing deal.

Synosis (South San Francisco, Calif.) was spun out of EuroVentures Inc., an incubator wholly owned by Versant Ventures, in early 2006. The company was formally launched this month after raising $32.5 million in December in a series A round through Versant; 5AM Ventures; Abingworth; and Novo A/S. ...